| Timothy Edward Mcalindon, MD, MPH | |
|
119 Belmont St, Worcester, MA 01605-2903 | |
| (508) 334-5224 | |
| Not Available |
| Full Name | Timothy Edward Mcalindon |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 42 Years |
| Location | 119 Belmont St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518931625 | NPI | - | NPPES |
| 110057007A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 153928 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pratt Medical Group Inc | 3375515661 | 265 |
News Archive
Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis and respiratory insufficiency, show findings from a randomised controlled trial.
Medworxx Inc., a leader in clinical patient flow, compliance and education solutions, today announces the addition of York Central Hospital in Richmond Hill, ON, to the Medworxx Patient Flow community, licensing 370 beds at the hospital. York Central is located in one of Canada's fastest growing communities, and now joins the fold of Medworxx Patient Flow clients representing 38% of acute-care beds in Ontario, and 30% nationwide.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has engaged the Numoda Corporation, a leading information, process and logistics management company, to oversee the Phase III clinical trial of DAVANAT and 5-FU compared with the standard of care in the treatment of patients with advanced, metastatic colorectal cancer.
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
› Verified 3 days ago
| Entity Name | Pratt Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275570319 PECOS PAC ID: 3375515661 Enrollment ID: O20040807000255 |
News Archive
Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis and respiratory insufficiency, show findings from a randomised controlled trial.
Medworxx Inc., a leader in clinical patient flow, compliance and education solutions, today announces the addition of York Central Hospital in Richmond Hill, ON, to the Medworxx Patient Flow community, licensing 370 beds at the hospital. York Central is located in one of Canada's fastest growing communities, and now joins the fold of Medworxx Patient Flow clients representing 38% of acute-care beds in Ontario, and 30% nationwide.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has engaged the Numoda Corporation, a leading information, process and logistics management company, to oversee the Phase III clinical trial of DAVANAT and 5-FU compared with the standard of care in the treatment of patients with advanced, metastatic colorectal cancer.
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Edward Mcalindon, MD, MPH Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Timothy Edward Mcalindon, MD, MPH 119 Belmont St, Worcester, MA 01605-2903 Ph: (508) 334-5224 |
News Archive
Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis and respiratory insufficiency, show findings from a randomised controlled trial.
Medworxx Inc., a leader in clinical patient flow, compliance and education solutions, today announces the addition of York Central Hospital in Richmond Hill, ON, to the Medworxx Patient Flow community, licensing 370 beds at the hospital. York Central is located in one of Canada's fastest growing communities, and now joins the fold of Medworxx Patient Flow clients representing 38% of acute-care beds in Ontario, and 30% nationwide.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has engaged the Numoda Corporation, a leading information, process and logistics management company, to oversee the Phase III clinical trial of DAVANAT and 5-FU compared with the standard of care in the treatment of patients with advanced, metastatic colorectal cancer.
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
› Verified 3 days ago
Dr. Adepeju Gbadebo Champion, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-2731 Fax: 774-442-4672 | |
Madaiah Lokeshwari, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-6849 | |
Sowmya Korapati, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-3550 Fax: 774-442-6715 | |
Irma Hashmi, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Madhav Sharma, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-5438 | |
Daniel M Steigman, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 123 Summer Street, Suite 390, Worcester, MA 01608 Phone: 508-368-3120 Fax: 508-368-3121 | |
Dr. Julia D Andrieni, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Department Of General Medicine, Worcester, MA 01655 Phone: 508-334-2731 |